Lineage, Inc. Common Stock (LINE)vsSite Centers Corp (SITC)
LINE
Lineage, Inc. Common Stock
$37.75
+0.96%
REAL ESTATE · Cap: $9.50B
SITC
Site Centers Corp
$2.82
-0.35%
REAL ESTATE · Cap: $150.60M
Smart Verdict
WallStSmart Research — data-driven comparison
Lineage, Inc. Common Stock generates 7576% more annual revenue ($5.37B vs $69.97M). SITC leads profitability with a 182.8% profit margin vs -3.1%. SITC earns a higher WallStSmart Score of 52/100 (C-).
LINE
Avoid35
out of 100
Grade: F
SITC
Buy52
out of 100
Grade: C-
Key Strengths & Concerns
Side-by-side fundamental analysis
Key Strengths
Reasonable price relative to book value
Attractively priced relative to earnings
Reasonable price relative to book value
Every $100 of equity generates 52 in profit
Keeps 183 of every $100 in revenue as profit
Conservative balance sheet, low leverage
Areas to Watch
0.8% revenue growth
0.0% earnings growth
Operating margin of 3.7%
Elevated debt levels
Smaller company, higher risk/reward
Weak financial health signals
Expensive relative to growth rate
Revenue declined 69.3%
Comparative Analysis Report
WallStSmart ResearchBull Case : LINE
The strongest argument for LINE centers on Price/Book.
Bull Case : SITC
The strongest argument for SITC centers on P/E Ratio, Price/Book, Return on Equity. Profitability is solid with margins at 182.8% and operating margin at -76.4%.
Bear Case : LINE
The primary concerns for LINE are Revenue Growth, EPS Growth, Operating Margin.
Bear Case : SITC
The primary concerns for SITC are Market Cap, Piotroski F-Score, PEG Ratio.
Key Dynamics to Monitor
LINE profiles as a turnaround stock while SITC is a declining play — different risk/reward profiles.
SITC carries more volatility with a beta of 1.02 — expect wider price swings.
LINE is growing revenue faster at 0.8% — sustainability is the question.
LINE generates stronger free cash flow (186M), providing more financial flexibility.
Bottom Line
SITC scores higher overall (52/100 vs 35/100), backed by strong 182.8% margins. Both earn "Buy" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.
This analysis is generated from publicly available financial data. Not financial advice.
Lineage, Inc. Common Stock
REAL ESTATE · REIT - INDUSTRIAL · USA
Lineage, Inc. (Ticker: LINE) is a pioneering biotechnology firm dedicated to regenerative medicine, focusing on next-generation cell therapies targeting ocular diseases, spinal cord injuries, and various cancers. With its proprietary technologies and robust strategic collaborations, Lineage is at the forefront of developing transformative treatment options that aim to improve patient outcomes significantly. The company's commitment to enhancing its diverse product pipeline and expediting clinical trials makes it an attractive investment opportunity for institutional investors seeking exposure in the rapidly evolving healthcare landscape.
Visit Website →Site Centers Corp
REAL ESTATE · REIT - RETAIL · USA
SITE Centers owns and manages outdoor shopping centers that provide a highly engaging shopping experience and product mix for retail partners and consumers.
Visit Website →Compare with Other REIT - INDUSTRIAL Stocks
Want to dig deeper into these stocks?